India to United States: Pantoprazole Export Trade Route
India has recorded 919 verified shipments of Pantoprazole exported to United States, representing a combined trade value of $876.6M USD. This corridor is served by 26 active Indian exporters, with an average shipment value of $953.9K USD. The leading Indian exporter is MYLAN LABORATORIES LIMITED, which accounts for 95% of total export value with 180 shipments worth $829.5M USD. On the buying side, MYLAN PHARMACEUTICALS INC, is the largest importer in United States with $816.1M USD in purchases. The top 3 suppliers — MYLAN LABORATORIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, TORRENT PHARMACEUTICALS LTD — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Pantoprazole corridor is one of India's established pharmaceutical export routes, with 919 shipments documented worth a combined $876.6M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 95% of all export value, reflecting the consolidated nature of India's pantoprazole manufacturing sector.
Across 26 active suppliers, the average shipment value stands at $953.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with pantoprazole's non-urgent bulk-order profile.
Shipment activity peaks during April-June, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 17.0%, placing it at rank #1 among India's top pantoprazole export destinations globally.
On the import side, key buyers of Indian pantoprazole in United States include MYLAN PHARMACEUTICALS INC,, EUGIA US LLC, MYLAN PHARMACEUTICALS INC and 54 others. MYLAN PHARMACEUTICALS INC, is the single largest importer with 57 shipments valued at $816.1M USD.
